Abnormal presynaptic catecholamine regulation in a hyperactive SNAP-25-deficient mouse mutant.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2001-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0091-3057(01)00481-6PMID 11526963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system

  2004cited by this paper
• Development of Coloboma (Cm/+), a mutation with anterior lens adhesion

  2004cited by this paper
• Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents

  2004cited by this paper
• Mice lacking the norepinephrine transporter are supersensitive to psychostimulants

  2000cited by this paper
• Transgenic rescue of SNAP-25 restores dopamine-modulated synaptic transmission in the coloboma mutant.

  1999cited by this paper
• Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.

  1999cited by this paper
• Coloboma Hyperactive Mutant Mice Exhibit Regional and Transmitter‐Specific Deficits in Neurotransmission

  1997cited by this paper
• Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

  1996cited by this paper
• Mouse Model of Hyperkinesis Implicates SNAP-25 in Behavioral Regulation

  1996cited by this paper
• Alpha 2-adrenoceptor mediated inhibition of [3H]dopamine release from nucleus accumbens slices and monoamine levels in a rat model for attention-deficit hyperactivity disorder.

  1995cited by this paper
• Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

  1995cited by this paper
• Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic.

  1995cited by this paper
• Deletion map of the coloboma (Cm) locus on mouse chromosome 2.

  1994cited by this paper
• SNAP receptors implicated in vesicle targeting and fusion

  1993cited by this paper
• A complex of rab3A, SNAP‐25, VAMP/synaptobrevin‐2 and syntaxins in brain presynaptic terminals

  1993cited by this paper
• On the structure of the ‘synaptosecretosome’ Evidence for a neurexin/synaptotagmin/syntaxin/Ca2+ channel complex

  1993cited by this paper
• A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion.

  1993cited by this paper
• Contribution of an α1-adrenergic receptor subtype to the expression of the “ventral tegmental area syndrome”

  1992cited by this paper
• Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2

  1992cited by this paper
• Clonidine treatment of Gilles de la Tourette's syndrome.

  1991cited by this paper
• The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations

  1989cited by this paper
• Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine.

  1989cited by this paper
• Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.

  1989cited by this paper
• The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?

  1988cited by this paper
• Repeated low dose apomorphine induced subsensitivity of presynaptic dopamine receptors.

  1987cited by this paper
• Reversal of supersensitive apomorphine-induced rotational behavior in mice by continuous exposure to apomorphine.

  1986cited by this paper
• EFFECT OF CLONIDINE ON PLATELET ALPHA2‐ADRENORECEPTORS AND PLASMA NOREPINEPHRINE OF CHILDREN WITH TOURETTE SYNDROME

  1985cited by this paper
• Diagnosis and management of attention deficit disorder: a pediatric perspective.

  1984cited by this paper
• Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup

  1983cited by this paper
• Clonidine in the treatment of Tourette syndrome: a review of data.

  1982cited by this paper
• Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice.

  1981cited by this paper
• Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system.

  1981cited by this paper
• Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following α-methyltyrosine or Reserpine

  1979cited by this paper
• Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat.

  1978cited by this paper
• A review of stimulant drug research with hyperactive children.

  1977cited by this paper
• Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction.

  1976cited by this paper
• The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic system.

  1975cited by this paper
• A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain

  1975cited by this paper
• Behavioral activation of rats during intraventricular infusion of norepinephrine.

  1970cited by this paper

• Animal models of attention-deficit/hyperactivity disorder: Diversity and validity.

  2025cites this paper
• An updated review on animal models to study attention-deficit hyperactivity disorder

  2024cites this paper
• THE TRANSLATIONAL GENETICS OF ADHD AND RELATED PHENOTYPES IN MODEL ORGANISMS.

  2022cites this paper
• Review of Rodent Models of Attention Deficit Hyperactivity Disorder.

  2021cites this paper
• Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications.

  2021cites this paper
• Localising movement disorders in childhood.

  2019cites this paper
• SNAP-25 in Major Psychiatric Disorders: A Review.

  2019cites this paper
• Disturbed neurotransmitter homeostasis in ether lipid deficiency

  2019cites this paper
• Prolyl oligopeptidase and alpha-synuclein in the regulation of nigrostriatal dopaminergic neurotransmission

  2019cites this paper
• On the Effects of Sensory Noise in ADHD

  2018cites this paper
• Replicated association of Synaptotagmin (SYT1) with ADHD and its broader influence in externalizing behaviors.

  2017cites this paper
• The Association of SNAP25 Gene Polymorphisms in Attention Deficit/Hyperactivity Disorder: a Systematic Review and Meta-Analysis

  2017cites this paper
• Exploring the Validity of Proposed Transgenic Animal Models of Attention-Deficit Hyperactivity Disorder (ADHD)

  2017cites this paper
• EFFECTIVENESS OF SOME HERBAL DRUGS ON THE STATIONARY ROD IN MICE

  2017cites this paper
• The Relationship between the SNAP-25 Polymorphism and Omission Errors in Korean Children with Attention Deficit Hyperactivity Disorder

  2017cites this paper
• A review of the role of synaptosomal-associated protein 25 (SNAP-25) in neurological disorders

  2017cites this paper
• Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models.

  2016cites this paper
• SNARE complex in developmental psychiatry: neurotransmitter exocytosis and beyond

  2016cites this paper
• Characterisation of the Superior Colliculus in a Rat Model of Attention Deficit/Hyperactivity Disorder

  2015cites this paper
• Transgenic mouse models for ADHD

  2013cites this paper
• Evaluation of the Neurokinin-1 receptor knockout mouse model of Attention Deficit Hyperactivity Disorder

  2013cites this paper
• Rodent models of ADHD.

  2012cites this paper
• Role of SNAP25 Explored in Eastern Indian Attention Deficit Hyperactivity Disorder Probands

  2012cites this paper
• CAUSES AND CONSEQUENCES OF REDUCED EXPRESSION OF SNAP-25 IN NEURONAL NETWORKS

  2012cites this paper
• CAUSES AND CONSEQUENCES OF REDUCED EXPRESSION OF SNAP-25 IN NEURONAL NETWORKS G3R Tutor: Prof.ssa Michela MATTEOLI Coordinatore: Prof. Alberto PANERAI

  2012cites this paper
• Analysis of sensory, motor and cognitive functions of the coloboma (C3Sn.Cg‐Cm/J) mutant mouse

  2011influential citation
• Overview of Animal Models of Attention Deficit Hyperactivity Disorder (ADHD)

  2011influential citation
• PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES

  2011cites this paper
• Animal models of ADHD.

  2011cites this paper
• An association study between SNAP-25 gene and attention-deficit hyperactivity disorder.

  2011cites this paper
• Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

  2011cites this paper
• Transgenic Mouse Models of Childhood Onset Psychiatric Disorders

  2011cites this paper
• Brain distribution of genes related to changes in locomotor activity.

  2010cites this paper
• Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review

  2010cites this paper
• A Novel Mechanism and Treatment Target for Presynaptic Abnormalities in Specific Striatal Regions in Schizophrenia

  2010cites this paper
• D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

  2010cites this paper
• SNAP‐25 in Neuropsychiatric Disorders

  2009cites this paper
• Evidence that putative ADHD low risk alleles at SNAP25 may increase the risk of schizophrenia

  2009cites this paper
• 2.4 Synaptic Vesicle Associated Proteins and Schizophrenia

  2009cites this paper
• Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.

  2009cites this paper
• Allelic variants of SNAP25 in a family-based sample of ADHD

  2008cites this paper
• Deletion of 7q11.23 Genes and Williams Syndrome

  2008cites this paper
• The hyperactive syndrome: metanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity.

  2008cites this paper
• Neurobiology of animal models of attention-deficit hyperactivity disorder.

  2007cites this paper
• Reprint of "Neurobiology of animal models of attention-deficit hyperactivity disorder".

  2007cites this paper
• Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD.

  2007cites this paper
• Calcyon mRNA expression in the frontal-striatal circuitry and its relationship to vesicular processes and ADHD

  2007cites this paper
• D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD.

  2007cites this paper
• Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.

  2007cites this paper
• The α2C-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder

  2006cites this paper
• Behavioral and Brain Functions

  2006cites this paper
• The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder.

  2006cites this paper
• The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder

  2005cites this paper
• What can we learn from Animal Models of ADHD ?

  2005cites this paper
• Behavioral and Brain Functions

  2005cites this paper
• The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder

  2005cites this paper
• Association of norepinephrine transporter gene with methylphenidate response.

  2004cites this paper
• Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD

  2004cites this paper
• Synaptogenesis and heritable aspects of executive attention.

  2003cites this paper
• Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma.

  2003cites this paper
• Animal models of attention-deficit hyperactivity disorder.

  2003cites this paper
• Expression of catecholaminergic mRNAs in the hyperactive mouse mutant coloboma.

  2001cites this paper
• THE MOLECULAR AND BEHAVIORAL CONSEQUENCES OF ABNORMAL NORADRENERGIC NEUROTRANSMISSION IN THE HYPERACTIVE SNAP-25 DEFICIENT MOUSE MUTANT COLOBOMA

  2001cites this paper